Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zai Lab Ltd ADR (ZLAB)

Zai Lab Ltd ADR (ZLAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zai Lab Ltd ADR 4560 JINKE ROAD BLDG. 1 4F PUDONG SHANGHAI F4 201210 CHN

www.zailaboratory.com Employees: 2,175 P: 86-21-6163-2588 F: 216-163-2570

Description:

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.

Key Statistics

Overview:

Market Capitalization, $K 2,956,854
Enterprise Value, $K 2,166,704
Shares Outstanding, K 108,628
Annual Sales, $ 266,720 K
Annual Net Income, $ -334,620 K
Last Quarter Sales, $ 102,270 K
Last Quarter Net Income, $ -41,670 K
EBIT, $ -338,200 K
EBITDA, $ -332,500 K
60-Month Beta 0.99
% of Insider Shareholders 13.88%
% of Institutional Shareholders 41.65%
Float, K 93,550
% Float 86.12%
Short Volume Ratio 0.38

Growth:

1-Year Return 1.79%
3-Year Return -56.69%
5-Year Return -31.33%
5-Year Revenue Growth 205,069.23%
5-Year Earnings Growth -32.58%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -2.77
EPS Growth vs. Prev Qtr 48.78%
EPS Growth vs. Prev Year 40.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ZLAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.97%
Return-on-Assets % -27.10%
Profit Margin % -125.46%
Debt/Equity 0.17
Price/Sales 10.95
Price/Cash Flow N/A
Price/Book 4.01
Book Value/Share 6.70
Interest Coverage -0.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar